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Abstract
Background
Onchocerciasis transmission across international borders is not uncommon, yet a coordi-
nated cross border stops mass drug administration (MDA) decision has not been
documented.
Methods/Principle findings
The Galabat-Metema focus involves neighboring districts on the border between Sudan and
Ethiopia. Mass drug administration (MDA) was provided once and subsequently twice per
year in this focus, with twice-per-year beginning in Ethiopia’s Metema subfocus in 2016 and
in the Sudan’s Galabat subfocus in 2008. Ov16 ELISA-based serosurveys were conducted
in 6072 children under 10 years of age in the Metema subfocus in 2014, and 3931 in the
Galabat in 2015. Between 2014 and 2016, a total of 27,583 vector Simulium damnosum
flies from Metema and 9,148 flies from Galabat were tested by pool screen PCR for Oncho-
cerca volvulus O-150 DNA. Only 8 children were Ov16 seropositive (all in the Metema sub-
focus); all were negative by skin snip PCR. The upper limit of the 95% confidence interval
(UCL) for Ov16 seropositive was <0.1% for the overall focus and 0.14 positive fly heads per
2000 (UCL = 0.39/2000). However, an entomological ‘hotspot’ was detected on the Wudi
Gemzu river in Metema district. The hotspot was confirmed when 4 more positive fly pools
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were found on repeat testing in 2017 (1.04 L3/2000 flies (UCL = 2.26/2000). Information
exchange between the two countries led to stopping MDA in a coordinated fashion in 2018,
with the exception of the hotspot at Wudi Gemzu, where MDA with ivermectin was increased
to every three months to hasten interruption of transmission.
Conclusion
Coordinated stop MDA decisions were made by Sudan and Ethiopia based on data satisfy-
ing the World Health Organization’s criteria for interruption of onchocerciasis transmission.
Definitions of entomological ‘hotspots’ and buffer zones around the focus are proposed.
Author summary
Onchocerciasis is a vector-borne tropical disease caused by the parasitc worm, Onchocerca
volvulus. The vector is Simulium flies that breed in fast flowing rivers and streams. The
infection can cause skin disease and loss of vision, giving risk to the common name of
‘river blindness’ for the condition. Ivermectin (Mectizan) mass drug administration
(MDA) given at high coverage for many years can interrupt transmission such that MDA
can eventually be stopped. The present paper provides highlights of onchocerciasis trans-
mission interruption in the first known coordinated international cross border focus with
ivermectin MDA program in Africa, where 99% of the global onchocerciasis burden
exists. This focus known as Galabat-Metema is shared between Ethiopia and Sudan, both
of which have established a nationwide policy for elimination of onchocerciasis. The
paper provides the history of MDA in the border area and the results leading a coordi-
nated end to MDA in the focus in 2017.
Introduction
Human onchocerciasis is a neglected tropical disease (NTD) caused by a vector-borne parasitic
filarial worm, Onchocerca volvulus (Nematode: Filaroidea). Adult male and female worms liv-
ing in subcutaneous nodules produce embryos (microfilariae) that are ingested during a blood
meal by day-biting black flies (Diptera: Simuliidae: Simulium) that breed in fast flowing rivers
and streams. The microfilariae develop in the fly into infective larval stages that can then be
transmitted to another person during subsequent blood-feeding. In the human host microfi-
lariae are responsible for a pruritic, often discoloring, dermatitis and visual impairment that
may lead to blindness.
In sub-Saharan Africa, mass drug administration (MDA) of the medicine ivermectin (Mec-
tizan, donated by Merck & Co) kills microfilariae, thus reducing skin and eye disease and
impeding transmission of the infection. The medicine has little initial impact on the adult
worms, and so must be given repetitively over many years. Community-led distribution of
ivermectin (referred to as Community Directed Treatment with ivermectin—CDTI) is the
main MDA strategy [1]. In the CDTI strategy, community members are educated and empow-
ered to select trusted representatives who are then trained to treat the eligible populations
residing in their respective communities. This strategy has successfully been used in Africa,
where 99% of onchocerciasis occurs, to deliver ivermectin MDA once or twice-yearly [2, 3].
Galabat-Metema cross-border onchocerciasis focus
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Onchocerciasis transmission zones may cross international borders and so present a unique
challenge of coordination between the different national program activities on each side of the
border. We refer to such areas as ‘Special Intervention Zones’ (SIZs) borrowing from terminol-
ogy used by the now closed Onchocerciasis Control Program of West Africa (OCP). SIZs in
the OCP context referred to transmission zones that required unique solutions to address spe-
cial programmatic challenges (at times including those related to cross-national border issues)
[4]. The Galabat-Metema onchocerciasis focus is a transmission area comprising two ‘subfoci’
in neighboring countries: Galabat in Gadarif State of Sudan and Metema in North Gondar
Zone of the Amhara Region of Ethiopia-Figs 1 and 2. This SIZ requires special consideration
and coordinated operations in the context of the two national elimination programs. Fortu-
nately, Sudan and Ethiopia each has a national policy for nationwide onchocerciasis transmis-
sion elimination using twice-per-year ivermectin MDA. Sudan launched its elimination policy
in December 2006, while Ethiopia did so in 2012 [3, 5].
The present paper describes a collaborative effort between Sudan and Ethiopia to interrupt
transmission of onchocerciasis in the Galabat-Metema focus. We will present the history of
the two programs, their ivermectin MDA activities and results from parasitological, serologi-
cal, and entomological surveys conducted between 2014 and 2017 that resulted in a coordi-
nated 2017 decision to stop MDA, in accord with 2016 World Health Organization (WHO)
guidelines [6]. We also briefly describe the Sudanese decision to continue MDA in Galabat
until Ethiopia completed its transmission assessments, and Ethiopia’s decision to continue
treatment activities in an entomological ‘hot-spot’ in Metema district called Wudi Gemzu.
Finally, the lessons learned with respect to buffer zones between these and other onchocerciasis
foci, and operations in a Special Intervention Zone will be discussed.
Onchocerciasis epidemiology and MDA in the Galabat-Metema
transmission zone
Onchocerciasis as a cross border phenomenon on the border between Sudan and Ethiopia was
recognized by the WHO World Bank African Programme for Onchocerciasis Control
(APOC) supported Rapid Epidemiological Mapping of Onchocerciasis (REMO) exercises con-
ducted between 1998–2000 (Table 1 and Fig 1).
REMO data based on nodule rates showed a prevalence range of 14–44% in 17 villages in
the Metema district and 0–18% among 14 villages in Galabat. The area was designated the
Galabat-Metema focus consisting of two subfoci: 1) the Galabat ‘subfocus’ encompassing the
political boundaries of Galabat (now split into Galabat and El Quresha) and 2) the Metema
‘subfocus’ comprising Metema and West Armachiho district. The population in the Galabat
subfocus was 146,536 in 2017, while that of the Metema subfocus was 173,923: the entire Gala-
bat-Metema SIZ has a population of 320,459.
Onchocerciasis in Sudan’s Galabat subfocus was first documented in 1975 [7]. In this area,
onchocerciasis presents as a severe form of skin disease characterized by darkened skin
(‘sowda’) associated with severe pruritus [8]. Sowda is a localized and usually asymmetrical
[9–11]. In sowda, the number of microfialariae (mf) in skin is very low compared to other
onchocerciasis regions of sub-Saharan Africa [12]. In the original description, mf prevalence
(determined by skin snip examination of 40 individuals in Mushar Ghanam and Sundus com-
munities) was 52.5% [13]. This study was followed by another study in 1985 in which 63% of
173 persons assessed had sowda [8]. In early 1994, communities in Galabat were involved in
ivermectin clinical trials, but treatment was discontinued after the study was completed [14].
Annual MDA in a programmatic setting was finally launched late in 2007 (Figs 2 and 3). Based
on a successful experience of twice-per-year MDA in the Abu Hamad focus, MDA in Galabat
Galabat-Metema cross-border onchocerciasis focus
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was increased to twice a year in 2011 until 2014 when the program returned to annual treat-
ment as described later in this paper. The first round of MDA in 2007 reached 52,151 people.
Subsequent rounds generally increased in scope, peaking at 133,626 in the first of two rounds
in 2013 (Figs 2 and 3); an average of 77,166 people were treated per round. Annual coverage
was always below 90% of the treatment goal (defined as 84% of the total population), but
twice-per-year coverage exceeded 90% in each round. Treatments in the Galabat subfocus
ended in 2017.
Onchocerciasis in Ethiopia’s Metema district was first reported around the same time as
was Galabat, in the early 1970s [15]. Studies on sowda in Metema were never conducted, but
unpublished reports indicated that onchoceral skin disease was a major problem in the district.
Annual MDA was launched in Metema district in 2003 and continued until 2016 when twice-
per-year treatment was launched (Figs 2 and 3). MDA continued in the new West Armachiho
Fig 1. Baseline Rapid Epidemiological Mapping of Onchocerciasis (REMO) conducted in and around the Galabat- Metema Onchocerciasis focus (based of 1998–
2011 nodule prevalence surveys, see Table 1. Not copyrighted, and was created in ArcGIS.
https://doi.org/10.1371/journal.pntd.0007830.g001
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district that was carved out of Metema district in 2008. In the Metema district the number of
treatments ranged from 77,629 persons in 2003 to 142,501 in 2017. Coverage of the eligible
population ranged from 80% to 100% with a mean of about 91%. In West Armachiho District,
treatments ranged from 18,921 in 2008 to 42,337 in 2017. Treatment coverage of eligible popu-
lation ranged from 79% to 100% with a mean of about 93%. The second round of 2017 was
restricted to the hotspot at Wudi Gemzu (population = 11,592, or 3.6% of the focus), for rea-
sons discussed later. Treatments ended elsewhere in the focus in 2017 in a coordinated fashion
with the Galabat subfocus.
Fig 2. Number of MDA ivermectin treatments provided once or twice yearly in Galabat sub-focus (Sudan) and Metema sub-focus in Metema and West
Armachiho districts of Ethiopia) - 2003–2017. Not copyrighted, and was created in Ms Excel.
https://doi.org/10.1371/journal.pntd.0007830.g002
Table 1. Rapid Epidemiological Mapping for Onchocerciasis (REMO) conducted in Galabat and Metema between 1998 to 2011.
Country District Year REMO was Conducted No. of Villages surveyed Mean Nodule Prevalence (%) Range (%)
Sudan Galabat 2000 5 5.6 0–18
Ethiopia Metema 1998–2000 17 12 14–44
Chilga 2000–2001 12 14.6 3–46
Quara 2000–2001 4 31 27–41
Tach Armachiho (West Armachiho) 2001 1 14 NA
Tegede 2011 6 22.8 4–37
Alefa (Takusa) 2011 3 6 0–14
TOTAL 48 15.14 0–46
NA = Not Applicable
https://doi.org/10.1371/journal.pntd.0007830.t001
Galabat-Metema cross-border onchocerciasis focus
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Materials
Serology and entomology assessments were conducted to determine if each of the subfoci
(Galabat and Metema) could meet the requirements of the 2016 WHO guidelines for stopping
MDA [16–19]. These are demonstrating an 95% Upper Confidence Limit [UCL]) of< 0.1%
OV16 antibody prevalence in children aged less than 10 years of age, and a UCL< 1 third-
stage O. volvulus larva/2000 vector black flies (<0.05%). Sampling in each subfocus was con-
ducted to get a minimum of 3000 dried blood spots (DBS), obtained by standard finger stick
technique, from children five to just under 10 years of age, and at least 6000 vectors per focus.
Serological assessments
In the Galabat subfocus, DBS from children were purposively collected in 2015 from 9 com-
munities: a) three known endemic sentinel villages; b) four with a known history of onchocer-
ciasis, and c) two close to the border with Ethiopia. In addition, 21 of 34 first line villages and 5
of 26 second line villages (determined based on REMO guidelines) were randomly selected. A
total of 3,931 DBS were collected from children resident in these thirty-nine villages, repre-
senting 65% of the total of sixty villages in Galabat subfocus. Testing of the Sudanese samples
by OV16 ELISA took place in the onchocerciasis molecular laboratory of the Ministry of
Health in Khartoum.
In the Metema sub-focus, the DBS samples from 5 years to<10 year old children obtained
in 2014 in two separate field outings. Mobilization with village leaders occurred shortly before
each field visit. After communities were mobilized, parents were requested to bring their chil-
dren to a community center usually deemed central and convenient to all the families. West
Armachiho in particular had 13 sub-villages attached to the only four existing indeginous vil-
lages (‘kebeles’). In the first round (March 2014), the target sample size was allocated across all
villages in Metema District proportionally to the estimated population. Based on the
Fig 3. Treatment Coverage of the eligible population of ivermectin MDA provided once or twice yearly in Galabat subfocus and The Metema subfocus (Metema
and West Armachiho districts), by year (2003–2017). Not copyrighted, and was created in Ms Excel.
https://doi.org/10.1371/journal.pntd.0007830.g003
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household registers in every village under ivermectin treatment, children from 5 years to<10
years of age appeared to be about 9% of the population. This category of children were then
selected by convenience from communities ‘high’ risk for onchocerciasis due to their proxim-
ity to rapidly flowing water, and a known history of Simulium fly biting.
The second round of testing (July 2014) occurred in parts of northern Metema and West
Armachiho districts, focusing on children resident in villages close to the Agbara River (that
forms part of the border with Sudan) as well Angereb River in West Armachiho. Villages were
again chosen purposively, and after mobilization parents with their children were invited to
convenient central locations in the villages for DBS sampling. The target sample size per village
was again determined proportionally. Only resident children were selected for DBS in Metema
and West Armachiho districts. A total of 6072 children (4,369 from Metema District and 1,703
from West Armarchiho District) were assessed from 27 villages in Metema District and 4 Vil-
lages in West Armachiho District. Testing of the Ethiopian samples by OV16 ELISA took
place in the onchocerciasis molecular laboratory of the Ethiopian Public Health Institute in
Addis Ababa using the same protocol as used in Khartoum.
In the whole Galabat-Metema focus, a total of 10,003 five to under 10-year-old children
were tested for the presence of IgG4 antibodies recognizing the Ov16 antigen [20]. DBS from
each child were properly labeled before packing, transportation from the field and storage in
desiccated plastic bags in a deep freezer (-20˚C). In the laboratory, the serum samples eluted
from DBS were exposed to plates coated with purified recombinant Ov16–glutathione S-trans-
ferase (GST) antigen. Bound antibodies then were detected by exposure to biotin conjugated
goat anti-human IgG4, and streptavidin conjugated with alkaline phosphatase. The plates were
developed with paranitrophenol phosphate (PNPP) substrate (Sigma Chemical, St. Louis,
MO). Putatively positive samples were retested with plates coated with Ov16–GST and with
control GST. Samples that provided positive readings in both Ov16 assays and were negative
for GST alone were scored as confirmed positive.
From Ov16 positive children, skin snips were collected and analyzed with standard O-150
polymerase chain reaction (PCR) distinguishing patent infection from exposure [21, 22]. In
accordance with WHO guidelines, in circumstances where there are under 10 children found
to be OV16 positive, those who are also PCR negative do not need to be considered as positive
for infection in prevalence and confidence interval (CI) calculations. Confidence intervals
(CIs) in sampled locations with no positives were calculated with the Bayes Critical Point from
Poolscreen, for locations with confirmed positives, the conventional 95% CI formula was
applied [23].
Entomological assessments
Simulium flies were collected according to standard human landing capture procedures from
07:00–18:00 hours during the transmission season in four fly collection sites of Metema Dis-
trict and three of West Armachiho. In Galabat, Simulium flies were collected at three sites
along the Atbara River. Also, fly collection was done according to standard human landing
capture procedures from 07:00–18:00 hours during the transmission season, ten days a month
for nine months from June 2014 to February, 2015. [18, 19] The flies were preserved in 95%
alcohol in the field, and then taken to the Ethiopia Public Health Institute in Addis Ababa
(Ethiopia) and Ministry of Health Khartoum (Sudan) national molecular laboratories, where
they were morphologically identified as Simulium damnosum complex, placed into pools, and
tested by standard O-150 polymerase chain reaction (PCR) to detect O. volvulus DNA[23].
Aside from pool size, techniques were the generally performed under the same protocol in the
two laboratories. The pools analyzed contained only heads that had been separated from the
Galabat-Metema cross-border onchocerciasis focus
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007830 February 6, 2020 7 / 17
bodies as previously described [24]. The heads were then analyzed using the standard O-150
PCR assay [25]. Positive pools were confirmed by a second PCR. In Galabat, 9,148 Simulium
flies (comprising 140 pools) collected during 2014/2015 period from three fly collection points
were tested. In the Metema area, 27, 583 Simulium flies (162 pools) were collected from Octo-
ber 2014 to the end of December 2016 from seven vector collection sites. They were tested in
pools containing a maximum of 200 flies. For the entire focus, 36,731 S. damnosum flies were
tested.
The head pools provided an estimate of the infectivity rate (the prevalence of flies carrying
only L3 infective larvae in the head), and the Pool Screen software (Version 2.0; University of
Alabama, Birmingham, AL) was used to estimate the proportion of positive head pools in the
PCR assay and the associated 95% confidence intervals (95% CIs) [25]. Interruption of trans-
mission based on entomological criterion for stopping interventions was defined as per WHO
guidelines as the 95% ULCI of<1 infective fly per 2000 (0.05%) flies tested.
Mapping exercise in adjacent districts
Prior to the assessments mentioned above in Metema sub focus, the status of onchocerciasis in
the neighbouring districts was unknown. It was prudent to rapidly determine the status of
transmission in the adjacent districts before the stop MDA decision is made. Standard field
operating procedures (SFOPs) for mapping onchocerciasis developed by the Federal Ministry
of Health (FMoH) were applied [26, 27]. River prospections were done and potential breeding
sites along the rivers identified with associated first line “at risk” villages for onchocerciasis
selected for sampling. In each village, 100 children (5 to�10 years) were included in order to
ascertain any recent exposure to onchocerciasis, and 10 adults� 20 years of age (adults resi-
dent in their communities for at least 10 years) were selected for collection of DBS. The sam-
ples taken from adults provided an indication of long term exposure to onchocerciasis. In each
district, three villages were selected. The districts involved were Alefa, Chilga, Quara, Takusa,
and Tach Armachiho. A total of 1500 DBS was collected from children and 150 from adults
from a total of 15 villages.
Six Simulium flies collection sites were established (Alefa-1 site, Chilga-1, Quarra-2, and
Tach Armachiho- 2). Fly collection was also done according to standard human landing cap-
ture procedures from 07:00–18:00 hours during the transmission over a period of three
months from October to December 2016. Fly collection was done two days a week for two
weeks per month for about thirteen months from November 2015 to November 2016. DBS
and flies collected were processed in Ethiopia as described above and all OV16 positive chil-
dren were tested by skin snip PCR.
Ethics statement
The study was approved by the Federal Ministry of Health, Ethiopia and the Emory Institu-
tional Review Board as a routine program monitoring activity and therefore, classified as a
“non-research” activity. Before the surveys were conducted, district leaders and health workers
were informed of the objectives and importance of the surveys. These informed leaders and
health workers then organized and educated the leaders in the selected communities about the
planned surveys and their importance in determining whether onchocerciasis transmission
had been interrupted. Then the date and time to meet with community members at their
respective community centers for health education about onchocerciasis, why surveys were
needed to determine the status of transmission, who should be involved, and why informed
consent was necessary. During the community meetings, the responsible community leaders
and health workers explained the importance of the study and requested verbal informed
Galabat-Metema cross-border onchocerciasis focus
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consent from each selected community. Then after, selected adult subjects were again
requested to provide informed verbal consent before being assessed. Every individual had the
right to opt out without fear of repercussions. For children, additional informed consent was
obtained from their respective parents who accompanied them to the selected centers within
their resident communities during the surveys.
Results
Serological results
The evaluation in Metema District in 2014 showed 8 OV16 positive children all of whom
tested negative by skin snip PCR (Table 2, and Fig 4). According to 2016 WHO guidelines the
OV16 positive children were not to be included in the final tallies. Therefore, results are shown
as 0% (95% CI, 0%-0.032%).
In Galabat subfocus, there were also no positive Ov16 ELISA results in the 2015 assessments
(95% CI, 0% - 0.049%) (Table 2 and Fig 4). For the entire Galabat-Metema focus the 95% UCL
was 0.038%, thus meeting WHO stop MDA serological guidelines.
Entomological results
There were no positive pools for the DNA of O. volvulus from the 9,148 flies (140 pools) from
the Galabat subfocus, (0 L3 per 2000 flies, 95% UCL = 0.42/2000) (Table 3). In the Metema
area, although there were 2 of 162 pools (n = 27,583 flies) that were PCR positive, the overall
result for the subfocus met the WHO guideline threshold of<1 L3/2000 flies (0.1/2000, 95%
UCL = 0.39/2000). Both positive pools were from the collection site on the Wudi Gemzu river
(Table 3 and Fig 4). An epidemiological “hot spot” was suspected, prompting collection of an
additional 7,884 Simulium flies from May to August 2017 at that same site. Analysis of these
flies in 81 pools yielded an additional four positive pools (1.04 L3/ 2000 flies, 95% UCL = 2.26/
2000). The repeat entomological testing therefore confirmed the 2014 to 2016 period results of
a hot spot. Note that the 2017 results from Wude Gemzu are not included in Table 3.
Results from the adjacent districts
Serology. There were 17 (1.13%) Ov16 positives out of a total of 1,500 children assessed
(Table 4). These children were from adjacent districts of Alefa, Chilga, Takusa, and Quara.
While the positive children were all skin snip PCR negative, WHO guidelines do not allow
more than 10 Ov16 positive/PCR negative children, and therefore we did not proceed to addi-
tional sampling for a stop MDA exercise in these districts. There were also 10 (6.67%) Ov16
positive adults from areas south of the Metema subfocus in Alefa (3), Quarra (6) and Takusa
Table 2. Ov16 ELISA and skin snip PCR results from stop MDA assessments in the Galabat-Metema focus (2014–2015).
Country Locality/ District (year
tested)
Ov16 ELISA Skin Snip PCR on
Ov16-positive children
Final Results
Children<10 years
old
No. (%)
positive
No. tested No. (%) PCR
positive
No. positive/ No.
tested
Percent positive (95%
CI)
Sudan Galabat (2015) 3931 0 (0%) - - 0/3931 0 (0% - 0.049%)
Ethiopia Metema (2014) 4,369 8 (0.26%) 8 0 (0%) 0/4,369 0 (0% - 0.061%)
West Armachiho (2014) 1,703 0 (0%) - - 0/1,703 0 (0% - 0.065%)
Ethiopia subtotal 6072 8 (0.13%) 8 0 (0%) 0/6072 0 (0% - 0.032%)
Total 10,003 8 (0.08%) 8 0 (0%) 0/10,003 0 (0% - 0.038%)
https://doi.org/10.1371/journal.pntd.0007830.t002
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(1). Children and adults to the east of Metema (from Chilga and Tach Armachiho districts)
were negative.
The Ov16 results (shown in Fig 5) are not associated with the Metema subfocus, but are
found further to the south in an adjacent focus known as the Metekel transmission zone. The
area between the Metema and Metekel did not have positive Ov16 samples.
Entomology. Overall, 38,160 flies (193 pools) collected from districts adjacent to Metema
subfocus yielded 4 positive pools for the DNA of O. volvulus (0.21 L3/2000 flies, 95%
UCL = 0.46/2000), below the WHO threshold. There were two positive pools from southern
Quara District and two from Alefa District (Table 5). All positive fly pools were at least 20 km
from Metema subfocus limits and within the Metekel transmission zone (Fig 5). The area to
the south between the Metema subfocus and the Metekel transmission zone, which contained
positive fly pools, seemed to be free from onchocerciaisis infection.
Fig 4. Map of Galabat-Metema focus showing the sites where Stop MDA Ov16 serological and entomological PCR surveys were conducted. ‘Also shown is the
Wudi Gemzu Hotspot. The eight OV16 positive children in the transmission zone were all skin snipped PCR negative’. Not copyrighted and was created in ArcGIS.
https://doi.org/10.1371/journal.pntd.0007830.g004
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Discussion
Interruption of transmission in each subfocus, and in the overall cross
border transmission zone
Entomological and serological results met WHO criteria for stopping MDA in the cross border
Galabat-Metema focus when taken as a whole, or taken individual for subfoci in each country
[19]. This decision was taken considering 1) the presence of 8 OV16 positive, but skin snip
PCR negative children in Metema, and 2) the presence of an entomological hotspot in Wude
Gemzu. Outside the hotspot, the stop MDA decision was made and the rest of the focus was
moved in a coordinated and simultaneous fashion to a three-five year Post Treatment Surveil-
lance (PTS) period. A future companion report will describe how the Wude Gemzu hotspot
area shown on the maps in this report was delineated using Ov16 and entomological surveys.
Based on those surveys the decision was made to continue MDA in a combined population of
about 15,000 people with three monthly MDA with ivermectin until transmission interruption
is attained.
Table 3. PCR Results O. volvulus DNA in Simulium flies collected in Gababat (2015) and Metema/West Armachiho (2017).
Country Locality/
District
Lower
administrative unit/
Kebele
River Collection
point
Latitude
(decimal
degrees)
Longitude
(decimal
degrees)
No. of flies
analyzed
No. of pools
analyzed
No. of
positive
pools
Point estimate
per 2000 flies
(95% CI)
Sudan Galabat Gurasha Atbara Maudria 13.56667 36.30000 4,994 76 0 0 (0–0.77)
Galabat Atbaraey Atbara Hilat Khatir 13.57028 36.01667 2,022 30 0 0 (0–1.88)
Galabat East Atbaraey Atbara Guaiza 13.41667 36.08333 2,132 34 0 0 (0–1.79)
Subtotal 9,148 140 0 0 (0–0.42)
Ethiopia Metema Divico Wude
Gemzu
Wude
Gemzu
13.00668 36.28284 6,531 40 2 0.41 (0.08–1.13)
Metema Gubay Shinfa Gubay Jejeb 12.58857 36.24923 1,434 15 0 0 (0–2.62)
Metema Shinfa Shinfa Shinfa 12.55778 36.09612 1,779 9 0 0 (0–2.34)
Metema Meder 6 Guang Mender 6 12.91806 36.25553 1,000 5 0 0 (0–3.64)
West
Armachiho
Mahrish Angereb Mahrish 13.28857 36.66300 7,716 45 0 0 (0–0.49)
West
Armachiho
Abrhajira Angereb Abrhajira 13.17665 36.72022 6,259 32 0 0 (0–0.61)
West
Armachiho
Torka Torka Torka 13.46517 36.49490 2,864 16 0 0 (0–1.32)
Subtotal 27,583 162 2 0.14 (0.01–0.39)
Total 36,731 302 2 0.11 (0.008–
0.31)
�Additional testing of vectors from this site were positive by PCR. See text
https://doi.org/10.1371/journal.pntd.0007830.t003
Table 4. 2016 Ov16 ELISA from districts in and around the buffer zone bordering the Metema sub focus.
District Ov16 ELISA in children <10 years old Skin Snip PCR on Ov16-positive children Ov16 ELISA in adults�20 years old
No. assessed No. (%) positive No. tested No. (%) PCR positive No. assessed No. (%) positive
Alefa 300 6 (0.2%) 6 0 (0%) 30 3 (10.0%)
Takusa 300 1 (0.3%) 1 0 (0%) 30 1 (3.3%)
Chilga 300 2 (0.7%) 2 0 (0%) 30 0 (0%)
Quara 300 8 (2.7%) 8 0 (0%) 30 6 (20.0%)
Tach Armachiho 300 0 (0%) 0 0 (0%) 30 0 (0%)
Total 1,500 17 (1.13%) 17 0 (0%) 150 10 (6.7%)
https://doi.org/10.1371/journal.pntd.0007830.t004
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Fig 5. Delineated Map of Galabat- Metema Focus showing the Buffer Zone, the Hotspot, and the Transmission zone where MDA was halted] Not copyrighted,
and was created in ArcGIS.
https://doi.org/10.1371/journal.pntd.0007830.g005
Table 5. PCR Results for O. volvulus DNA in Simulium flies collected in and around the Buffer Zone (2016 and 2017).
District Collection point No. of flies analyzed No. of pools analyzed No. of positive pools Point estimate per 2000 flies (95% CI)
Alefa Godguadit Silassie 10,862 55 2 0.37 (0.03–1.03)
Quara Bambaho 26,214 132 2 0.15 (0.011–0.488)
Gelegu 974 5 0 0 (0–3.75)
Tach Armachiho Bebew 110 1 0 0 (0–26.6)
Ashere 0 0 0 -
Chilga Sinkua 0 0 0 -
Total 38,160 193 4 0.21 (0.05–0.46)
https://doi.org/10.1371/journal.pntd.0007830.t005
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Concepts of transmission and buffer zones
According to WHO, a transmission zone is ‘a geographical area where transmission of Oncho-
cerca volvulus occurs by locally breeding Simulium (black fly) vectors that can be regarded as a
natural ecological and epidemiological unit for intervention’[19]. We presumed in this envi-
ronment that 20 kilometers would be the maximum distance that S. damnosum s.l. vectors dis-
perse from their breeding sites [28–30]. The area around Metema subfocus limits that was free
from onchocerciaisis infection could be referred to as a “buffer” area. The ‘buffer zone’ could
be defined as at least a 20 km limit where infected flies cannot cross from one to another trans-
mission zone [28]. Separation of two transmission zones by a buffer zone would theoretically
allow for a ‘safe’ stop MDA decision in one transmission zone even if MDA had to continue in
a neighboring transmission zone. A buffer zone of at least 20 km around the Metema subfocus
has been shown in Fig 5.
When the results from entomological and serological surveys conducted in the adjacent dis-
tricts were plotted, positive results were not found in the buffer zone, but further to the south
in the Metekel transmission zone (in southern Quara, southern Takusa and Alefa Districts).
The only member of the S. damnosum complex found in the area was S. damnosum s.str. ’Gon-
dar Form’, and likely the vector. The area to the west of Quara District towards the Sudan bor-
der, and north of the National Park is uninhabited. The rest of northern Quara and Takusa
Districts adjacent to the Metema subfocus have seasonal rivers and the conditions for Simu-
lium fly breeding are not favourable. In addition, the absence of infected flies along the south-
ern edge of Metema subfocus was an indication that there are no infected migratory Simulium
flies from Metekel transmission zone to the south of the buffer zone. Although the REMO map
in Fig 1 shows possible onchocerciaisis prevalence in this area, there are a number of factors
such as seasonal labour movements during the agricultural season that may have had a drastic
impact on transmission in both the buffer zone and possibly neighbouring areas in Metema
District. The study recommended more sites for entomological surveillance during the PTS
period in order to ensure that no infected flies from Metekel transmission zone invade
Metema subfocus or the buffer area unnoticed.
The western and southern part of the Galabat subfocus is surrounded by an arid area with
no flowing rivers. To the east and north of the Angereb River in Tsegede District the area in
the buffer zone and beyond are uninhabited. For Galabat subfocus in Sudan, the Atbara/Setit
dam complex on Atbara River has submerged all the villages up to Khor Hamoda, close to
Umgazaz village (Fig 5) [31]. The lake has eliminated all possible fly breeding sites and
increased the size of the buffer area on the northern part of the Galabat-Metema focus.
On the eastern side of the Galabat-Metema focus, flies analyzed by PCR were negative for
infection, and OV 16 results were negative in children. The demonstration that a “buffer” zone
existed around the Galabat-Metema focus increased the confidence of Ethiopia and Sudan
ministries of health to stop MDA. The need for close monitoring of the focus during the PTS
period was emphasized when this decision was made.
Coordination of the Galabat and Metema Programs in the cross-border
focus
The two programs collaborated by attending each other’s technical meetings, presenting data
from each subfocus, and establishing consensus for assessments and recommendations. Peri-
odic joint field visits and synchronized MDA exercises for maximum impact on transmission
also were conducted. Each country’s onchocerciasis molecular laboratories were responsible
for analyzing their own specimens. However, the laboratories used the same protocol and
enjoyed the same technical support and oversight from the University of South Florida WHO
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onchocerciasis reference diagnostics laboratory. Of particular note is that when Sudan’s assess-
ments in 2015 established that transmission had been interrupted in its Galabat subfocus, the
Sudanese program officials agreed to continue annual MDA while waiting for Ethiopia to
complete its own stop MDA assessments in Metema subfocus in 2016. This generous offer
allowed for a thorough discussion by both parties of the Wude Gemzu hot spot prior to a coor-
dinated stop MDA decision on both sides of the border.
Special intervention zones (SIZ)
The term “Special intervention zones” was coined just prior to the closure of Onchocerciasis
Control Programme (OCP). SIZs referred to zones of ongoing onchocerciasis transmission
and morbidity requiring continued programmatic activities [32]. SIZs, many of which were
cross border in nature, were funded for continued and heightened interventions under the
African programme for Onchocerciasis Control (APOC) through the end of 2007. We propose
that the term SIZ be routinely used for cross border transmission areas that are by nature
more challenging to eliminate because of the need for binational coordination and special
activities [4]. Ethiopia and Sudan (being sovereign nations having different health, financial,
security and information sharing policies) presented unique challenges for successful interrup-
tion of the cross border Galabat-Metema focus. The close coordination and cooperation of the
binational teams were fundamental in forging trusting personal relationships and common
interpretation of data needed for Sudan to offer to continue MDA until Ethiopia had com-
pleted its assessments, and for both countries to make the joint decision to stop MDA.
Conclusion
The Galabat-Metema cross-border focus has met the criteria set forth by WHO guidelines for
interruption of transmission of O.volvulus. This was accomplished by a combination of annual
and semiannual ivermectin MDA. MDA was halted at the end of 2017 in a coordinated bina-
tional manner through a process of close collaboration and communication between the gov-
ernments of Sudan and Ethiopia. Several lessons were learned from this experience: 1) A
‘Special Intervention Zone’ approach is useful to address the unique political dynamics that
exist in international border areas. 2) The decision to stop MDA should be supported by
peripheral rapid assessments that can demonstrate a ‘buffer zone’ separating the area in ques-
tion from other areas with ongoing transmission. 3) The Stop MDA decision was made despite
the presence of an entomological ‘hotspot’. Intensive (four times per year) MDA is ongoing in
this hotspot, as well as comprehensive Post Treatment Surveillance for recrudescence in the
remainder of the focus.
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